These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23178242)

  • 1. The identification of dysfunctional crosstalk of pathways in Parkinson disease.
    Diao H; Li X; Hu S
    Gene; 2013 Feb; 515(1):159-62. PubMed ID: 23178242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
    Wang Y; Wang Z
    Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra.
    Noureddine MA; Li YJ; van der Walt JM; Walters R; Jewett RM; Xu H; Wang T; Walter JW; Scott BL; Hulette C; Schmechel D; Stenger JE; Dietrich F; Vance JM; Hauser MA
    Mov Disord; 2005 Oct; 20(10):1299-309. PubMed ID: 15966006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
    Liang J; Lv J; Liu Z
    Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
    Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
    Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.
    Ohnuki T; Nakamura A; Okuyama S; Nakamura S
    Brain Res; 2010 Jul; 1346():26-42. PubMed ID: 20513370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.
    Li J; Sun Y; Chen J
    J Mol Neurosci; 2018 Aug; 65(4):527-535. PubMed ID: 30083784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of microarray datasets to identify Parkinson's disease‑associated pathways and genes.
    Feng Y; Wang X
    Mol Med Rep; 2017 Mar; 15(3):1252-1262. PubMed ID: 28098893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.
    Soreq L; Ben-Shaul Y; Israel Z; Bergman H; Soreq H
    Neurobiol Dis; 2012 Mar; 45(3):1018-30. PubMed ID: 22198569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson's disease.
    Liu H; Huang Y; Li J
    J Integr Neurosci; 2018; 17(3-4):619-631. PubMed ID: 30010140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
    Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U
    Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
    Su L; Wang C; Zheng C; Wei H; Song X
    BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
    Bisht I; Ambasta RK; Kumar P
    Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting Differential Gene Expression Analysis for Cyto-Architectural Alterations in Substantia Nigra of Parkinson's Disease Patients Reveals Known and Potential Novel Disease-Associated Genes and Pathways.
    Ferraro F; Fevga C; Bonifati V; Mandemakers W; Mahfouz A; Reinders M
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Kong P; Lei P; Zhang S; Li D; Zhao J; Zhang B
    Neurosci Lett; 2018 Jan; 662():51-58. PubMed ID: 28965931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genes associated with disc degeneration identified using microarray gene expression profiling and bioinformatics analysis.
    Chen Y; Chen K; Li M; Li C; Ma H; Bai YS; Zhu XD; Fu Q
    Genet Mol Res; 2013 Apr; 12(2):1431-9. PubMed ID: 23661466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease.
    Kelly J; Moyeed R; Carroll C; Albani D; Li X
    Mol Brain; 2019 Feb; 12(1):16. PubMed ID: 30819229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.